Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of interferon in the new era of hepatitis C treatments.

Expert review of gastroenterology & hepatology - 1 Aug 2014

Parekh Parth J, Shiffman Mitchell L

Abstract excerpt

Interferon has been the backbone of HCV treatment since this agent was first introduced nearly two decades ago. Interferon acts to eradicate HCV via two mechanisms: by directly inhibiting HCV replication via an indirect anti-viral mechanism and by modulating an immune response against hepatocytes infected with HCV. The current treatment of chronic HCV genotype 1 is the combination of peginterferon, ribavirin and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Design
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferons

Share to Remission Induction

Share to Treatment Outcome

Source

Identifiers

PMID: 24758387
DOI: 10.1586/17474124.2014.910453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of interferon in the new era of hepatitis C treatments.PMID 24758387Read ↗

Current and emerging therapeutic approaches to hepatitis C infection.Semantic proximity Read ↗

Emerging therapies for hepatitis C virus.Semantic proximity Read ↗

The evolving treatment of chronic hepatitis C: where we stand a decade out.Semantic proximity Read ↗

Emerging Trends in Non-Interferon-Based Genotype-Specific Antiviral Agents: Pharmaceutical Perspectives.Semantic proximity Read ↗

Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection.Semantic proximity Read ↗

Interferons in the management of viral hepatitis.Semantic proximity Read ↗

Hepatitis C treatment: an incipient therapeutic revolution.Semantic proximity Read ↗

Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?Semantic proximity Read ↗

Big Changes Are Coming in Hepatitis CSemantic proximity Read ↗

Hepatitis C in 2011: A new standard of care and the race towards IFN-free therapy.Semantic proximity Read ↗

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting AntiviralsSemantic proximity Read ↗

Interferon-free regimens: the near future, the likely and the not so likely.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.